Covid 19 Treatment
Covid 19 Treatment News
New COVID-19 treatment rules: India cuts down use of Remdesivir, Tocilizumab, multivitamins, steroids
According to the new guidelines, Remdesivir may be considered only in patients who have completed 10 days since the start of the symptoms and require supplemental oxygen.
ICMR says Molnupiravir has major safety concerns, not included in national protocol for COVID-19 treatment
Dr Balram Bhargava, director-general of ICMR, said that contraceptive methods should be used for three months if the drug is administered to women since the child may have problems
While the market for these drugs may not be huge at present due to a drop in COVID-19 cases and extended timelines, experts believe that these drugs will help control future waves and protect people with weak immunity
WHO recommends antibody treatment for COVID-19 infected people who have a high risk of hospitalisation
The Regeneron cocktail of synthetic antibodies - casirivimab and imdevimab - has been found to reduce the risk of hospitalisation for unvaccinated, elderly or immunosuppressed patients with Covid.
The drug comes in powder form in a sachet of 2.34 g and the MRP has been fixed at Rs 990.
The algorithm was developed by the Foundation for Innovations in Health, Kolkata and SEED division of the Department of Science and Technology.
No GST on black fungus medicines, 5% tax on vaccines to stay: Complete list of tax cuts on COVID essentials
The Council stated that tax cuts will remain in effect till 30 September, and can be extended further upon nearing the deadline
COVID-19 impact: Odisha techie airlifted to Chennai for treatment after kin raise Rs 70 lakh via crowdfunding
The 24-year-old techie had contracted COVID-19 while taking care of his corona-positive parents. He later developed pneumonia and septicaemia in the lungs and requires a lung transplant to stay alive
Unseen Warriors of COVID: In UP's Bijnor, paramedics and local doctors help villagers wary of hospitals
From checking up on patients showing symptoms of COVID-19, to providing them with medicines at low cost, physicians and paramedic staff provided the much-needed care as Bijnor battled the second wave
Roche launches COVID-19 'Antibody Cocktail' in India at Rs 59,750 per dose; Cipla to market drug in country
In a joint statement, the pharma giants said that the second batch of the Antibody Cocktail (Casirivimab and Imdevimab) will be available by mid-June
These guidelines are categorised on the basis of severity of the infection: mild and asymptomatic, moderate and severe.
Ganga Ram hospital Chairperson Dr DS Rana said, "Medicines that do not have any activity to work, will have to be discontinued."
Manipuri journalist and activist arrested under NSA for FB posts rejecting cow dung, urine as cure for COVID-19
Journalist Kishorchandra Wangkhem and activist Erendro Leichombam were granted bail on Monday for their social media posts, but the government subsequently invoked the NSA to re-arrest them
The state government has decided to set up separate wards as treatment for Mucormycosis, also known as black fungus infection, needed ophthalmologists, ENT specialists, neuro and plastic surgeons, etc, under the same roof
'You are looting people': Kerala HC slams private hospitals, lauds LDF govt's price cap on COVID-19 treatment
The Pinarayi Vijayan government has capped the price of the general ward at Rs 2,500, which includes nursing, boarding, blood transfusion, and oxygen services
The drug 2-deoxy-D-glucose (2-DG) comes in powder form in a sachet and is taken orally by dissolving it in water, the defence ministry said
The decision comes after many state governments have objected to different prices of the vaccines, with Delhi Chief Minister Arvind Kejriwal saying this is not time for "profiteering"
In a letter to Narendra Modi, K Palaniswami said the differential pricing mechanism placed a higher financial burden on states
Addressing a press briefing, NITI Aayog's Dr VK Paul said considering the current COVID-19 situation, people should wear a mask even while at home and avoid stepping out unnecessarily.
The Biden administration had earlier come under criticism from several quarters for not releasing surplus COVID-19 vaccines to India, which is experiencing its worst-ever public health crisis